?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
The Issue
Our Solutions
Biosimilars 101
Foundations
Core Principles
FDA Regulatory Tenets
Biosimilars FAQs
Future Evolution of Biosimilar Development
Approved Biosimilars
Advocacy
Our Action
Tools
News
Resources
Get Involved
Partners
signalgroup
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
May 22, 2025
signalgroup
Biosimilars Forum Submits Comments to Accelerate Safe and Effective Biosimilar Development by Modernizing the FDA and Eliminating Bureaucratic Inefficiencies
News
May 13, 2025
signalgroup
Biosimilars Forum Applauds House of Representatives Committee on Energy and Commerce for Including PBM Reform in Reconciliation Package
News
May 13, 2025
signalgroup
The Biosimilars Forum Submits Comments Highlighting Biosimilars as Safe and Effective Lower-Cost Medicines for Americans that Need Them
News
April 16, 2025
signalgroup
Biosimilars Forum Applauds the Trump Administration for Drug Pricing Executive Order
News
April 15, 2025
signalgroup
Biosimilars Forum Statement on Tariffs Impacting Low Cost Medicines
News
April 8, 2025
signalgroup
Biosimilars Forum Urges Congressional Action on Biosimilars
News
April 2, 2025
signalgroup
Biosimilars Forum Supports the FDA, Its Employees, and Its Mission
News
March 26, 2025
signalgroup
Biosimilars Forum Executive Director Juliana Reed to Speak at Evolution of Biosimilars Development Workshop
News
March 24, 2025
signalgroup
Biosimilars Forum Chair of Scientific Affairs Committee to Speak at the Festival of Biologics USA
News
July 24, 2024
signalgroup
The Biosimilars Forum Supports House Committee on Oversight and Accountability Probe Into the PBM Monopoly
01
02
03
Next page